Intellia - NTLA Operatsion marja

Intellia (NTLA) kompaniyasining korporativ logotipi

CRISPR patent asosi Intellia Therapeutics (NTLA) kompaniyasiga noyob patologiyalar terapiyasi sohasida uzoq muddatli yetakchilikni va'da qilmoqda, buni ebit marjasi dinamikasi isbotlaydi. -821.20 qiymati ushbu baholash parametrini xarakterlaydi. AI va robototexnika qo'llanilishi dori vositalari sintezini tezlashtirmoqda, garchi yakuniy testlar ekspert nazoratini talab qilsa-da. Irsiy kasalliklarni davolashdagi inqilobiy ishlanmalar hozirda kelajakdagi foyda siklini shakllantirmoqda.

intelliatx.com (NTLA): Operatsion foyda marjasi 04.07.2022dan 20.11.2026gacha

Intellia Therapeutics, Inc. (NTLA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Fundamental baholash:Intellia Corp, NTLA
intelliatx.com brendining mahsuloti

Operatsion marja xarajatlarni boshqarish samaradorligini o'lchaydi va moliyaviy xarajatlar hamda soliqlarni hisobga olgunga qadar asosiy operatsiyalardan olingan foyda ulushini ko'rsatadi. Intellia Therapeutics (NTLA) uchun ushbu metrika CRISPR terapiyalarini ishlab chiqish xarajatlarini va laboratoriya resurslarini xavfsiz utilizatsiya qilish bilan bog'liq xarajatlarni aks ettiradi. Biznesning operatsion marjasini tahlil qilish ushbu sog'liqni saqlash gigantining o'z tadqiqotlarini kengaytirish qobiliyatini baholash imkonini beradi. Ko'rsatkichning tendentsiyasi innovatsiya siklining haqiqiy xarajatlarini ochib beradi. Investorlar uchun ushbu qiymatlarni mahsulotlarni tijoratlashtirish sur'atlari bilan solishtirish juda muhimdir.

Raqobatchilar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion rentabellik Stoke Corp (STOK)|Operatsion faoliyat rentabelligi BioLife|Operatsion marja WVE (Wave Life Sciences Ltd)|MAZE: Operatsion foyda bo'yicha sotuv rentabelligi|Sionna Therapeutics, Inc. - Operatsion marja|Operatsion foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Sotuvning operatsion marjasi|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik